What is Experimur?
Experimur operates as a dedicated toxicology testing and research laboratory, offering extensive experience in conducting a wide array of pre-clinical (non-clinical) and regulatory toxicology studies. Their expertise spans from chronic and acute studies to specialized areas such as teratology, reproduction, pharmacokinetics, and neurotoxicity. The laboratory adheres strictly to FDA, EPA, and OECD testing guidelines and Good Laboratory Practices (GLPs), ensuring the highest standards of scientific rigor and compliance for its clients in the pharmaceutical and chemical industries.
How much funding has Experimur raised?
Experimur has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$737K
Debt (2020): $350K with participation from PPP
Debt (2021): $737K led by PPP
What's next for Experimur?
The recent major strategic investment in Experimur signals a strong confidence in its capabilities and market position within the critical field of toxicology research. This infusion of capital, contributing to the overall $1.1M raised, is expected to fuel further expansion of its research infrastructure, enhance its service offerings, and potentially broaden its regulatory compliance expertise. As Experimur continues to grow, it is poised to play an increasingly vital role in supporting the development and safety assessment of new products across various regulated industries, leveraging its established reputation for quality and precision in testing.
See full Experimur company page
